Business Description
Telo Genomics Corp
NAICS : 621511
SIC : 8681
ISIN : CA88555C1077
Description
Telo Genomics Corp is a personalized medicine company. The company through its wholly-owned subsidiary is engaged in the development and commercialization of diagnostic and prognostic products. The company is developing diagnostic and prognostic products for cancer and neurological disorders.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 39.24 | |||||
| Equity-to-Asset | 0.79 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -6.6 | |||||
| 3-Year EPS without NRI Growth Rate | -7.7 | |||||
| 3-Year FCF Growth Rate | -5.8 | |||||
| 3-Year Book Growth Rate | 24.9 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 75.22 | |||||
| 9-Day RSI | 62.54 | |||||
| 14-Day RSI | 57.82 | |||||
| 6-1 Month Momentum % | -18.34 | |||||
| 12-1 Month Momentum % | -43.13 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.07 | |||||
| Quick Ratio | 5.07 | |||||
| Cash Ratio | 4.48 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -19.9 | |||||
| Shareholder Yield % | 0.04 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -189.78 | |||||
| ROA % | -166 | |||||
| ROIC % | -3291.22 | |||||
| ROC (Joel Greenblatt) % | -3992.21 | |||||
| ROCE % | -185.72 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 10.59 | |||||
| Price-to-Tangible-Book | 13.02 | |||||
| EV-to-EBIT | -3.76 | |||||
| EV-to-EBITDA | -3.81 | |||||
| EV-to-FCF | -4.22 | |||||
| Price-to-Net-Current-Asset-Value | 13.02 | |||||
| Price-to-Net-Cash | 13.02 | |||||
| Earnings Yield (Greenblatt) % | -26.6 | |||||
| FCF Yield % | -21.36 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:TDSGF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Telo Genomics Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.036 | ||
| Beta | 0.06 | ||
| Volatility % | 67.11 | ||
| 14-Day RSI | 57.82 | ||
| 14-Day ATR ($) | 0.007177 | ||
| 20-Day SMA ($) | 0.119955 | ||
| 12-1 Month Momentum % | -43.13 | ||
| 52-Week Range ($) | 0.0761 - 0.24 | ||
| Shares Outstanding (Mil) | 71.31 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Telo Genomics Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Telo Genomics Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Telo Genomics Corp Frequently Asked Questions
What is Telo Genomics Corp(TDSGF)'s stock price today?
The current price of TDSGF is $0.13. The 52 week high of TDSGF is $0.24 and 52 week low is $0.08.
When is next earnings date of Telo Genomics Corp(TDSGF)?
The next earnings date of Telo Genomics Corp(TDSGF) is .
Does Telo Genomics Corp(TDSGF) pay dividends? If so, how much?
Telo Genomics Corp(TDSGF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers